Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5948 Pancreatic Neoplasms 3563 Carcinoma, Hepatocellular 3273 Stomach Neoplasms 3057 Colonic Neoplasms 2328 Rectal Neoplasms 2192 Esophageal Neoplasms 1801 Liver Neoplasms 1247 Neoplasms 1181 Breast Neoplasms 1064 Neoplasm Metastasis 871 Carcinoma, Non-Small-Cell Lung 794 Lung Neoplasms 745 Cholangiocarcinoma 743 Gastrointestinal Neoplasms 662 Ovarian Neoplasms 630 Esophageal Squamous Cell Carcinoma 585 Prostatic Neoplasms 485 Melanoma 457 Biliary Tract Neoplasms 441 Head and Neck Neoplasms 376 Uterine Cervical Neoplasms 344 Carcinoma, Renal Cell 329 Gastrointestinal Stromal Tumors 326 Adenocarcinoma Of Esophagus 315 Sarcoma 304 Barrett Esophagus 300 Anus Neoplasms 284 Gallbladder Neoplasms 283 Endometrial Neoplasms 281

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oesophago-gastric Cancer × Gastrointestinal × Clear all

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡